BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 16133053)

  • 1. Glycation free adduct accumulation in renal disease: the new AGE.
    Thornalley PJ
    Pediatr Nephrol; 2005 Nov; 20(11):1515-22. PubMed ID: 16133053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced glycation end products in renal failure.
    Thornalley PJ
    J Ren Nutr; 2006 Jul; 16(3):178-84. PubMed ID: 16825015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry.
    Thornalley PJ; Battah S; Ahmed N; Karachalias N; Agalou S; Babaei-Jadidi R; Dawnay A
    Biochem J; 2003 Nov; 375(Pt 3):581-92. PubMed ID: 12885296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profound mishandling of protein glycation degradation products in uremia and dialysis.
    Agalou S; Ahmed N; Babaei-Jadidi R; Dawnay A; Thornalley PJ
    J Am Soc Nephrol; 2005 May; 16(5):1471-85. PubMed ID: 15800128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced glycation endproducts: what is their relevance to diabetic complications?
    Ahmed N; Thornalley PJ
    Diabetes Obes Metab; 2007 May; 9(3):233-45. PubMed ID: 17391149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assay of advanced glycation endproducts in selected beverages and food by liquid chromatography with tandem mass spectrometric detection.
    Ahmed N; Mirshekar-Syahkal B; Kennish L; Karachalias N; Babaei-Jadidi R; Thornalley PJ
    Mol Nutr Food Res; 2005 Jul; 49(7):691-9. PubMed ID: 15945118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced glycation end products in the pathogenesis of chronic kidney disease.
    Rabbani N; Thornalley PJ
    Kidney Int; 2018 Apr; 93(4):803-813. PubMed ID: 29477239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highlights and hotspots of protein glycation in end-stage renal disease.
    Thornalley PJ; Rabbani N
    Semin Dial; 2009; 22(4):400-4. PubMed ID: 19708990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pathogenesis and consequences of AGE formation in uraemia and its treatment.
    Dawnay A; Millar DJ
    Cell Mol Biol (Noisy-le-grand); 1998 Nov; 44(7):1081-94. PubMed ID: 9846890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of protein glycation, glycated peptides, and glycation free adducts.
    Thornalley PJ
    Perit Dial Int; 2005; 25(6):522-33. PubMed ID: 16419322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal clearance of glycation adducts: anti-glycation defence in uraemia and dialysis.
    Dawnay A
    Biochem Soc Trans; 2003 Dec; 31(Pt 6):1386-9. PubMed ID: 14641069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced glycation end-products: implications for diabetic and non-diabetic nephropathies.
    Daroux M; Prévost G; Maillard-Lefebvre H; Gaxatte C; D'Agati VD; Schmidt AM; Boulanger E
    Diabetes Metab; 2010 Feb; 36(1):1-10. PubMed ID: 19932633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced glycation endproducts in food and their effects on health.
    Poulsen MW; Hedegaard RV; Andersen JM; de Courten B; Bügel S; Nielsen J; Skibsted LH; Dragsted LO
    Food Chem Toxicol; 2013 Oct; 60():10-37. PubMed ID: 23867544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of oxidized and glycated proteins in clinical samples using mass spectrometry--a user's perspective.
    Thornalley PJ; Rabbani N
    Biochim Biophys Acta; 2014 Feb; 1840(2):818-29. PubMed ID: 23558060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of proximal tubular metabolism of advanced glycation end products in kidney diseases.
    Saito A; Takeda T; Sato K; Hama H; Tanuma A; Kaseda R; Suzuki Y; Gejyo F
    Ann N Y Acad Sci; 2005 Jun; 1043():637-43. PubMed ID: 16037287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced glycation end product free adducts are cleared by dialysis.
    Agalou S; Ahmed N; Thornalley PJ; Dawnay A
    Ann N Y Acad Sci; 2005 Jun; 1043():734-9. PubMed ID: 16037300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of Serum Advanced Glycation Endproducts Reveals Methylglyoxal-Derived Advanced Glycation MG-H1 Free Adduct Is a Risk Marker in Non-Diabetic and Diabetic Chronic Kidney Disease.
    Rabbani N; Adaikalakoteswari A; Larkin JR; Panagiotopoulos S; MacIsaac RJ; Yue DK; Fulcher GR; Roberts MA; Thomas M; Ekinci E; Thornalley PJ
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reading patterns of proteome damage by glycation, oxidation and nitration: quantitation by stable isotopic dilution analysis LC-MS/MS.
    Rabbani N; Thornalley PJ
    Essays Biochem; 2020 Feb; 64(1):169-183. PubMed ID: 32065835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetic threesome (hyperglycaemia, renal function and nutrition) and advanced glycation end products: evidence for the multiple-hit agent?
    Kanková K
    Proc Nutr Soc; 2008 Feb; 67(1):60-74. PubMed ID: 18234133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dicarbonyl intermediates in the maillard reaction.
    Thornalley PJ
    Ann N Y Acad Sci; 2005 Jun; 1043():111-7. PubMed ID: 16037229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.